Financing round completed
Qvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.
Category: News
Qvanteq’s technology in peer-reviewed journals
In vivo data involving Qvanteq’s surface technology was published in the April issue of the journal Eurointervention.
QUEST I FIM study completed
Qvanteq AG today announced that its QUEST I study was completed. The technology has shown safety in humans.
Qvanteq obtained government funding in the form of a new CTI/KTI project (19305.1 PFLS-LS)
The topic of this 18 month program is the “Investigation of in vitro response of human blood to Qvanteq’s anti-thrombotic and pro-healing surface technology applied on vascular stents”.
QUEST I clinical study, patient recruitment completed
Qvanteq AG today announced that it completed enrollment of QUEST I study patients.